Canine Parvovirus Monoclonal Antibody
66 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
66
Total Reports
38
Deaths Reported
5760.0%
Death Rate
Active Ingredients
Canine Parvovirus Monoclonal Antibody
Administration Routes
IntravenousUnknownSubcutaneousParenteralOral
Species Affected
Dog 66
Most Affected Breeds
Retriever - Labrador 7
Crossbred Canine/dog 6
Retriever - Golden 6
Pit Bull 4
Shepherd (unspecified) 4
Poodle - Standard 3
Poodle (unspecified) 3
Hound (unspecified) 3
Shih Tzu 3
Chihuahua 2
Most Reported Reactions
Death 26
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 25
Lethargy (see also Central nervous system depression in Neurological) 13
Diarrhoea 10
Vomiting 10
Not eating 9
Other abnormal test result NOS 9
Death by euthanasia 9
Leucocytosis NOS 7
Agonal breathing 6
Low creatinine 5
Hypoglycaemia 5
Outcome Breakdown
Died
29 (42.0%)
Outcome Unknown
16 (23.2%)
Ongoing
10 (14.5%)
Euthanized
9 (13.0%)
Recovered/Normal
5 (7.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.